ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
New analgesics could result from the recent identification of mutations that block a pain pathway. University of Cambridge medical geneticist C. Geoffrey Woods and colleagues studied members of three Pakistani families who are unable to feel pain. That inability may sound like a blessing, but pain is a useful signal to modify harmful behavior. Each of the members of the study group had suffered injuries, including fractures or bone infections that were "only diagnosed in retrospect because of painless limping or lack of use of a limb," the researchers report. They traced the Pakistanis' rare condition to mutations in the SCN9A gene (Nature 2006, 444, 894). The gene codes for Nav1.7, a subunit of a voltage-gated sodium channel that is abundant in pain-signaling neurons. Because the mutations produce nonfunctional Nav1.7, the researchers conclude that SCN9A is essential for feeling pain. They hope their findings will prompt a search for analgesics to target this sodium channel subunit in people without the Nav1.7 mutations.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X